Resources
Here you can find publications and other resources related to the DOASENSE products.
Please note that our products are for health care professional use only!
Recent Publications
- Harenberg J, Beyer-Westendorf J, Crowther M, Douxfils J, Elalamy I, Verhamme P, Bauersachs R, Hetjens S, Weiss C:
Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine — A Multicenter Trial
Thromb Haemost 2020; 120(01): 132-140
[Free open access download HERE]
- Favaloro EJ, Lippi G:
The Pointy End of Point-of-Care Testing for Direct Oral Anticoagulants
Thromb Haemost 2020;120:11–13. [download editorial]
- Harenberg J, Schreiner H, Hetjens S, Weiss C:
Detecting Anti-IIa and Anti-Xa Direct Oral Anticoagulant (DOAC) Agents in Urine using a DOAC Dipstick.
Semin Thromb Hemost 2019; 45: 275–284
[Free open access download HERE]
- Robert C. Gosselin, Dorothy M. Adcock, Jonathan Douxfils:
An update on laboratory assessment for direct oral anticoagulants (DOACs)
Int J Lab Hematol. 2019;41(Suppl. 1):33–39 [article]
- Brigitte Söllner:
DOAC Dipstick: Einfacher Nachweis von direkten oralen Antikoagulanzien aus dem Urin
Perfusion 2/2019: 54-56 (in German) [download article]
- Robert C. Gosselin, Dorothy M. Adcock, Shannon M. Bates, Jonathan Douxfils, Emmanuel J. Favaloro, Isabelle Gouin-Thibault, Cecilia Guillermo, Yohko Kawai, Edelgard Lindhoff-Last, Steve Kitchen:
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
Thromb Haemost 2018; 118(3): 437-450 [ICSH Guidelines] - J. Harenberg, S. Hetjens, R. Schreiner, R. Krämer, C. Weiss:
DOAC Dipstick for determination of absence or presence of direct oral anticoagulants and creatinine in urine
Res Pract Thromb Haemost 2018; 2(Suppl. 1): PB242 [Poster]
- J. Harenberg, U. Warttinger, S. Hetjens, R. Schreiner, C. Giese, H.-J. Roth, R. Krämer, C. Weiss:
Reliability and validity of point-of-care tests taken from urine samples of patients on therapy with Apixaban, Rivaroxaban and Dabigatran
Res Pract Thromb Haemost 2017; 1(Suppl1): PB454 [Poster]
- Harenberg J, Ahrens I, Bauersachs R, Haas S, Koscielny J, Kraemer R, Lindhoff-Last E, Prochaska J, Schellong S, Spannagl M, Wild P, Beyer-Westendorf J:
A qualitative point of care test to assess anticoagulant activity in urine samples of patients treated with non-vitamin K antagonist oral anticoagulants - a german consensus.
J Thromb Haemost 2015; 13(Suppl 2): 636-637 (PO356-Tue)
- Harenberg J, Du S, Wehling M, Zolfaghari S, Weiss C, Krämer R, Walenga J
Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study.
Clin Chem Lab Med. 2016 Feb 1; 54(2): 275-83
- Favaloro EJ, Lippi G
Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors.
Semin Thromb Hemost. 2015 Mar; 41(2): 208-27
- Harenberg J, Du S, Krämer S, Weiss C, Krämer R, Wehling M.
Patients' serum and urine as easily accessible samples for the measurement of non-vitamin K antagonist oral anticoagulants.
Semin Thromb Hemost. 2015 Mar; 41(2): 228-36
- Harenberg J, Krämer S, Du S, Weiss C, Krämer R
Concept of a point of care test to detect new oral anticoagulants in urine samples.
Thromb J. 2013 Aug 1; 11(1):15
Videos
Video material related to the DOASENSE product suite:
DOASENSE Technology Animation
Listen to what opinion leaders think about DOASENSE's scientific education activities (symposia, etc.):
NOTE: DOASENSE(TM) products may not be available or approved in your country.